Discontinuation report AURALGAN

Last updated on 2022-07-26 History
Report ID 165407
Drug Identification Number 02332477
Brand name AURALGAN
Common or Proper name AURALGAN
Company Name PALADIN LABS INC.
Market Status MARKETED
Active Ingredient(s) ANTIPYRINE BENZOCAINE
Strength(s) 54MG 14MG
Dosage form(s) SOLUTION
Route of administration OTIC OTIC
Packaging size 14mL
ATC code S02DA
ATC description OTHER OTOLOGICALS
Reason for discontinuation Manufacturing issues
Anticipated discontinuation date
Actual discontinuation date 2022-07-25
Remaining supply date 2021-11-01
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply No remaining supply
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 100 BLVD ALEXIS-NIHON, SUITE 600
SAINT-LAURENT, QUEBEC
CANADA H4M 2P2
Company contact information 1-866-340-1112 paladincs@endo.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2022-07-26 English Compare
v2 2022-07-25 French Compare
v1 2022-07-25 English Compare

Showing 1 to 3 of 3